semaglutide ban 2025 How compounders plan to continue making GLP-1s Compounded "semaglutide" is not FDA-approved

It is not on the 503B outsourcing-facility list and has no USP/NF monograph, so it cannot legally be compounded by US pharmacies for human use

For instance, 3.3 billion mg of semaglutide per year would be required for 25% of obese US adults to take 2.4 mg q1wk

(2021) demonstrated that escalating doses were well-tolerated in humans with no dose-limiting toxicities

V., Bernardes, A

In the long-term, these dynamics are likely to partially or fully resolve

This means that anything that could be a named drug, like BPC-157, would need full drug approval before a compounding pharmacy can legally compound it for human use